Focused Ultrasound for the Treatment of Neuropathic Pain

Status unconfirmed · Not applicable

Conditions studied: Neuropathic Pain

In brief

A possible treatment approach for neuropathic pain would employ a process designed to promote healthier function of the ventral posteromedial (VPM) and ventral posterolateral (VPL) thalamic nuclei. This study is designed to employ focused ultrasound technology to target the VPM and VPL thalamus among participants with ongoing neuropathic pain syndromes to evaluate for tolerability and early efficacy.

Key facts

Study ID

NCT04485208

Run by

Neurological Associates of West Los Angeles

People needed

40

Starts

2020-06-30

Expected to finish

2025-12-30

Last updated by the study team

2022-09-28

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• History of neuropathic pain (onset, location, intensity, duration, quality, aggravating factors)
• Confirmation of nervous system injury through imaging or negative or positive sensory signs confined to the corresponding bodily area
• Failure from at least 3 pharmacological treatments (e.g., antidepressants, anticonvulsants, opioids)
• At least 18 years of age

You may not qualify if…

• Subjects unable to give informed consent
• Subjects who would not be able to lay down without excessive movement in a calm environment
• Pregnancy, women who may become pregnant or are breastfeeding
• Subjects with scalp rash or open wounds on the scalp (for example from treatment of squamous cell cancer)

Where it is running

• Neurological Associates of West LA — Santa Monica, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.